• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哪些因素可预测杀微生物剂试验中的脱落?

What predicts non-retention in microbicide trials?

机构信息

FHI, Research Triangle Park, NC 27709, USA.

出版信息

Contemp Clin Trials. 2011 Jul;32(4):512-6. doi: 10.1016/j.cct.2011.03.008. Epub 2011 Mar 5.

DOI:10.1016/j.cct.2011.03.008
PMID:21382512
Abstract

BACKGROUND

Poor retention can reduce study power and thwart randomization, possibly resulting in biased estimates of effect. Some HIV prevention trials conducted in developing countries have been challenged by high loss to follow-up. Identifying factors associated with non-retention could lead to recruitment of women more likely to remain in the trial, potentially yielding greater efficiency and validity.

METHODS

We summarized retention rates and, using Cox regression, evaluated factors associated with non-retention in four trials of two candidate vaginal microbicides (1% C31G or SAVVY® and 6% cellulose sulfate or CS) conducted in multiple sub-Saharan African countries. We defined retention as completion of the trial, including those with an HIV outcome. Non-retention comprised participants randomized to a study arm who were either lost to follow-up or discontinued prior to infection with HIV.

RESULTS

7,367 women were enrolled and randomized in the four trials; 7,086 are included in this analysis. 1,514 (21.4%) participants were either lost to follow-up or had early discontinuation. In the final Cox model, the following baseline factors were associated with non-retention: younger age (hazard ratio [HR] = 0.95); less education (HR = 0.97); condom use at last sex (HR = 1.18); larger number of sex acts in a typical week (HR = 1.01); and baseline candidiasis or bacterial vaginosis (HR = 1.12).

CONCLUSIONS

Younger and less educated women were more difficult to retain in these microbicide trials. But these same traits may be associated with higher HIV infection rates. Enhanced retention methods focused on those at highest risk of non-retention and possibly infection will optimize study efficiency and validity.

摘要

背景

较差的保留率可能会降低研究效力并破坏随机分组,从而导致对疗效的估计产生偏差。一些在发展中国家开展的 HIV 预防试验因失访率高而受到挑战。确定与失访相关的因素可能会导致招募更有可能完成试验的女性,从而提高效率和有效性。

方法

我们总结了四项候选阴道杀微生物剂(1%C31G 或 SAVVY®和 6%硫酸纤维素或 CS)试验的保留率,并使用 Cox 回归分析评估了与失访相关的因素。我们将保留定义为完成试验,包括发生 HIV 结局的参与者。失访包括随机分配到研究组的参与者,他们要么失访,要么在 HIV 感染前停止参与。

结果

四项试验共纳入并随机分配了 7367 名女性;本分析包括 7086 名参与者。1514 名(21.4%)参与者失访或提前终止。在最终的 Cox 模型中,以下基线因素与失访相关:年龄较小(危险比 [HR] = 0.95);受教育程度较低(HR = 0.97);上次性行为时使用避孕套(HR = 1.18);典型周内的性活动次数较多(HR = 1.01);基线念珠菌病或细菌性阴道病(HR = 1.12)。

结论

在这些杀微生物剂试验中,较年轻和受教育程度较低的女性更难以保留。但这些相同的特征可能与更高的 HIV 感染率相关。针对那些失访和可能感染风险较高的女性,采取强化保留方法将优化研究效率和有效性。

相似文献

1
What predicts non-retention in microbicide trials?哪些因素可预测杀微生物剂试验中的脱落?
Contemp Clin Trials. 2011 Jul;32(4):512-6. doi: 10.1016/j.cct.2011.03.008. Epub 2011 Mar 5.
2
Challenges to microbicide introduction in South Africa.南非引入杀微生物剂面临的挑战。
Soc Sci Med. 2006 Aug;63(4):968-78. doi: 10.1016/j.socscimed.2006.02.019. Epub 2006 Apr 5.
3
Microbicide preference among young women in California.加利福尼亚州年轻女性对杀微生物剂的偏好
J Womens Health (Larchmt). 2006 Apr;15(3):281-94. doi: 10.1089/jwh.2006.15.281.
4
HIV/AIDS. At last, vaginal gel scores victory against HIV.艾滋病毒/艾滋病。最终,阴道凝胶在对抗艾滋病毒方面取得了胜利。
Science. 2010 Jul 23;329(5990):374-5. doi: 10.1126/science.329.5990.374. Epub 2010 Jul 19.
5
Safety and acceptability of cellulose sulfate as a vaginal microbicide in HIV-infected women.硫酸纤维素作为HIV感染女性阴道杀菌剂的安全性和可接受性。
AIDS. 2006 May 12;20(8):1109-16. doi: 10.1097/01.aids.0000226950.72223.5f.
6
Desired qualities and hypothetical contextual use of vaginal microbicides in a diverse sample of US women.美国不同女性样本中阴道杀微生物剂的理想特性及假设的情境使用情况。
Contraception. 2007 Oct;76(4):314-8. doi: 10.1016/j.contraception.2007.05.092. Epub 2007 Aug 28.
7
Differentiating normal from abnormal rates of genital epithelial findings in vaginal microbicide trials.在阴道杀微生物剂试验中区分生殖器上皮检查结果的正常与异常发生率。
Contraception. 2008 Feb;77(2):122-9. doi: 10.1016/j.contraception.2007.10.006. Epub 2007 Dec 27.
8
Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission.硫酸纤维素凝胶预防阴道HIV传播无效。
N Engl J Med. 2008 Jul 31;359(5):463-72. doi: 10.1056/NEJMoa0707957.
9
Many vaginal microbicide trial participants acknowledged they had misreported sensitive sexual behavior in face-to-face interviews.许多阴道微生物杀灭剂试验参与者承认,他们在面对面访谈中误报了敏感的性行为。
J Clin Epidemiol. 2009 Jul;62(7):759-65. doi: 10.1016/j.jclinepi.2008.07.011. Epub 2008 Nov 14.
10
Heterosexual anal intercourse has the potential to cause a significant loss of power in vaginal microbicide effectiveness studies.异性肛交可能会显著降低阴道杀微生物剂有效性研究的效力。
Sex Transm Dis. 2010 Jun;37(6):361-4.

引用本文的文献

1
Factors associated with vaccination completion and retention among HIV negative female sex workers enrolled in a simulated vaccine efficacy trial in Kampala, Uganda.与乌干达坎帕拉一项模拟疫苗功效试验中入组的 HIV 阴性女性性工作者的疫苗接种完成和保留相关的因素。
BMC Infect Dis. 2019 Aug 16;19(1):725. doi: 10.1186/s12879-019-4328-1.
2
Knowledge, Attitudes, and Experiences of HIV Pre-Exposure Prophylaxis (PrEP) Trial Participants in Botswana.博茨瓦纳艾滋病毒暴露前预防(PrEP)试验参与者的知识、态度和经历
World J AIDS. 2015 Mar;5(2):10-20. doi: 10.4236/wja.2015.51002. Epub 2015 Feb 12.
3
Characteristics of participants consenting versus declining follow-up for up to 10 years in a randomized clinical trial.
在一项随机临床试验中,同意随访长达10年与拒绝随访的参与者的特征。
Clin Trials. 2015 Dec;12(6):657-63. doi: 10.1177/1740774515590807. Epub 2015 Jun 29.
4
Reducing lost to follow-up in a large clinical trial of prevention of mother-to-child transmission of HIV: the Breastfeeding, Antiretrovirals and Nutrition study experience.在一项预防艾滋病母婴传播的大型临床试验中减少失访情况:母乳喂养、抗逆转录病毒药物与营养研究经验
Clin Trials. 2015 Apr;12(2):156-65. doi: 10.1177/1740774514562031. Epub 2014 Dec 17.
5
Influences on visit retention in clinical trials: insights from qualitative research during the VOICE trial in Johannesburg, South Africa.影响临床试验就诊保留率的因素:来自南非约翰内斯堡 VOICE 试验期间定性研究的见解。
BMC Womens Health. 2014 Jul 28;14:88. doi: 10.1186/1472-6874-14-88.
6
HIV incidence in a cohort of women at higher risk in Beira, Mozambique: prospective study 2009-2012.莫桑比克贝拉高危女性队列中的 HIV 发病率:2009-2012 年前瞻性研究。
PLoS One. 2014 Jan 27;9(1):e84979. doi: 10.1371/journal.pone.0084979. eCollection 2014.
7
The Motivations and Experiences of Young Women in a Microbicide Trial in the USA and Puerto Rico.美国和波多黎各一项杀微生物剂试验中年轻女性的动机与经历。
World J AIDS. 2013 Sep;3(3). doi: 10.4236/wja.2013.33023.
8
Cognitive mapping: using local knowledge for planning health research.认知绘图:利用本土知识进行卫生研究规划。
BMC Med Res Methodol. 2013 Jul 26;13:96. doi: 10.1186/1471-2288-13-96.
9
Retention of clinical trial participants in a study of nongonococcal urethritis (NGU), a sexually transmitted infection in men.非淋菌性尿道炎(NGU)临床试验参与者的保留,一种男性性传播感染。
Contemp Clin Trials. 2012 Jul;33(4):606-10. doi: 10.1016/j.cct.2011.12.004. Epub 2012 Jan 12.